New Jersey Medical School —also known as Rutgers New Jersey Medical School—is a graduate medical school of Rutgers University that has been part of the Rutgers Division of Biomedical and Health Sciences since the 2013 dissolution of the University of Medicine and Dentistry of New Jersey.

During the past decade, Rutgers New Jersey Medical School conducted 59 clinical trials. In the 10-year time frame, 59 clinical trials started and 65 clinical trials were completed, i.e. on average, 110.2% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 21 clinical trials were completed. i.e. 123.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Rutgers New Jersey Medical School" #1 sponsor was "National Cancer Institute (NCI)" with 37 trials, followed by "National Institute of Allergy and Infectious Diseases (NIAID)" with 26 trials sponsored, "Centers for Disease Control and Prevention" with 13 trials sponsored, "Rutgers, The State University of New Jersey" with 12 trials sponsored and "Gynecologic Oncology Group" with 12 trials sponsored. Other sponsors include 104 different institutions and companies that sponsored additional 67 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rutgers New Jersey Medical School" #1 collaborator was "National Cancer Institute (NCI)" with 35 trials as a collaborator, "NRG Oncology" with 13 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 13 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 9 trials as a collaborator and "US Department of Veterans Affairs" with 9 trials as a collaborator. Other collaborators include 182 different institutions and companies that were collaborators in the rest 149 trials.

According to Clinical.Site data, the most researched conditions in "Rutgers New Jersey Medical School" are "HIV Infections" (41 trials), "Tuberculosis" (11 trials), "Cervical Adenocarcinoma" (6 trials), "HIV Infection" (5 trials) and "Cervical Adenosquamous Carcinoma" (4 trials). Many other conditions were trialed in "Rutgers New Jersey Medical School" in a lesser frequency.

Most popular intervention types in "Rutgers New Jersey Medical School" are "Drug" (147 trials), "Other" (65 trials), "Biological" (47 trials), "Radiation" (27 trials) and "Procedure" (17 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (36 trials), "Placebo" (33 trials), "Quality-of-Life Assessment" (26 trials), "Paclitaxel" (19 trials) and "Questionnaire Administration" (15 trials). Other intervention names were less common.

The vast majority of trials in "Rutgers New Jersey Medical School" are 165 trials for "All" genders, 34 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Rutgers New Jersey Medical School". undefined are not yet recruiting, 26 are recruiting, 39 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 113 completed trials in Rutgers New Jersey Medical School, undefined suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Rutgers New Jersey Medical School, 15 "Phase 1" clinical trials were conducted, 67 "Phase 2" clinical trials and 81 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 14 trials that are defined as “Not Applicable".